Jupiter Asset Management LTD Innoviva, Inc. Transaction History

Jupiter Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$11.8 - $13.78 $317,054 - $370,254	-26,869 Reduced 5.38%	472,495 $6.26 Million
Q3 2022 Nov 10, 2022	SELL	$11.61 - $15.22 $2.95 Million - $3.86 Million	-253,700 Reduced 33.69%	499,364 $5.8 Million
Q2 2022 Aug 10, 2022	BUY	$14.32 - $19.88 $3.96 Million - $5.5 Million	276,691 Added 58.08%	753,064 $11.1 Million
Q1 2022 May 11, 2022	BUY	$15.39 - $20.25 $7.1 Million - $9.35 Million	461,502 Added 3103.37%	476,373 $9.22 Million
Q4 2021 Feb 11, 2022	SELL	$15.91 - $18.72 $146,451 - $172,317	-9,205 Reduced 38.23%	14,871 $259,000
Q3 2021 Nov 10, 2021	BUY	$13.06 - $17.24 $314,432 - $415,070	24,076 New	24,076 $403,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.